---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-012356"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:32:02.148415+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Iradimed reports record Q4 revenue $22.7M, EPS $0.50; raises dividend to $0.20

## Summary
- Q4 2025 revenue $22.7M (+17% YoY); GAAP diluted EPS $0.50 (+25%), non-GAAP $0.54 (+23%).
- Full year 2025 revenue $83.8M (+14% YoY); GAAP diluted EPS $1.75 (+17%), non-GAAP $1.93 (+16%).
- Quarterly dividend raised 18% to $0.20/share from $0.17, payable March 6, 2026 to holders of record Feb 23.
- FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.06-2.21.
- Initial 3870 next-gen MRI pump shipped in Q4; full rollout begins Q1 2026 with meaningful H2 revenue contribution.

## SEC filing metadata
- accession: 0001104659-26-012356
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/0001104659-26-012356-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/irmd-20260210x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-012356
- JSON: https://secwatch.observer/filing/0001104659-26-012356.json
- Plain text: https://secwatch.observer/filing/0001104659-26-012356.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.